Clinical Characteristics and Molecular Profiling of <i>SF3B1</i>-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice. [PDF]
Wang RR +5 more
europepmc +1 more source
Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice. [PDF]
Ma YY, Zhang C, Chen Y, Zeng L, Zhang X.
europepmc +1 more source
SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study. [PDF]
Cui T +6 more
europepmc +1 more source
A rare cytogenetically cryptic <i>MECOM</i> rearrangement in a patient with myelodysplastic neoplasm and <i>SF3B1</i> mutation identified by RNA sequencing: a case report. [PDF]
Jin Y +7 more
europepmc +1 more source
P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS
J. Senapati +9 more
openaire +2 more sources
CO36 | TGF-β pathway deregulation in SF3B1-mutated low risk myelodysplastic syndrome patients
Introduction. Myelodysplastic syndromes (MDS) associated with mutations in genes belonging to the splicing machinery, such as SF3B1, SRSF2, U2AF1 and ZRSR2, are characterized by inefficient hematopoiesis and variable risk of evolving into AML. Mutations
Eleonora Lumia
doaj
U2AF2 controls alternative splicing in speckle-proximal regions in an RS domain-dependent manner. [PDF]
Pankivskyi S +5 more
europepmc +1 more source
Serendipity: Decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia [PDF]
Abboud, Camille N +7 more
core +3 more sources
Two-Step Algorithmic Selection of Interspecies Sequence-Mismatch-Based Housekeeping Genes for Precise Gene-Expression Assessment in PBMC-Humanized NSG Mice. [PDF]
Jo M +9 more
europepmc +1 more source
SF3B1K700E mutation in human embryonic stem cells causes aberrant expression of immune-related genes. [PDF]
Dastpak M +13 more
europepmc +1 more source

